buletin farmasi 06/2013

Upload: afiq83

Post on 03-Apr-2018

222 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 Buletin Farmasi 06/2013

    1/12

    ISU BULAN INI:

    HYPERTENSION

    ISI KANDUNGAN

    EDISIJUN

    2013

    EDISIJUN

    2013

    EDISIJUN

    2013

    PKDPASIR

    MAS

    PKDPASIR

    MAS

    PKDPASIR

    MAS

    SIDANG EDITORIAL

    PENASIHAT :

    NOR AFIFAH RAHIMI

    EDITOR

    NURUNNUHA MOHD NAWI

    PENGARANG

    NORUL IZZA AB RAHMAN

    WAN HAZNI TUAN AZIZ

    ARINA LIANA ISMAIL

    MUHAINI ABD HADI

    FARAH HANNAN

    MOHD MAZELAN

    TOPIC PAGE

    WHAT IS HYPERTENSION? 2

    CHRONIC HYPERTENSION 2

    PRE-ECLAMPSIA 3

    ECLAMPSIA 4

    MEDICATIONS USED IN HYPERTENSION 5 - 7

    KUIZ 8

    NEWLY HYPERTENSION DRUG IN CLINIC 9

    PERGERAKAN KAKITANGAN DI PKD PASIR MAS 9

    SEJENAK SEKETIKA DI LUAR 10

    QUOTES 11

  • 7/28/2019 Buletin Farmasi 06/2013

    2/12

    High blood pressure is a common condition in which the force of the blood against your artery walls is

    high enough that it may eventually cause health problems, such as heart disease.

    Blood pressure is determined by the amount of blood your heart pumps and the amount of resistanceto blood flow in your arteries. The more blood your heart pumps and the narrower your arteries, the

    higher your blood pressure.

    You can have high blood pressure (hypertension) for years without any symptoms. Uncontrolled high

    blood pressure increases your risk of serious health problems, including heart attack and stroke.

    High blood pressure typically develops over many years, and it affects nearly everyone eventually. For-tunately, high blood pressure can be easily detected. And once you know you have high blood pres-

    sure, you can work with your doctor to control it.

    (source : mayoclinic.com)

    is diagnosed when hypertension is confirmed before pregnancy or before 20 weeks gestation(blood pressure >140 mmHg systolic and/or >90 mmHg diastolic).

    is frequently diagnosed when high blood pressure fails to resolve post-partum.

    Women with chronic hypertension require careful

    monitoring during pregnancy as they have an increased risk of adverse events, including superim-

    posed pre-eclampsia, placental abruption, fetal growth restriction, premature delivery and still-

    birth.

  • 7/28/2019 Buletin Farmasi 06/2013

    3/12

    is defined as:

    New onset of hypertension(BP 140/90mmHG) after 20 weeks gesta-

    tion.

    No other features to suggest pre-eclampsia (no proteinuria)

    Normalisation of blood pressure within three months postpartum.

    Gestational hypertension is associated with adverse pregnancy out-

    comes if it progresses to pre-eclampsia or if hypertension is severe

    (170/110 mmHg)

    Final diagnosis only made postpartum

    Hypertension (140/90 mmHg) with onset after 20 weeks gestation with previously normal BP

    Renal manifestations

    - Significant proteinuria

    - Serum creatinine >90 micromol/L (or renal failure)

    - Oliguria

    Haematological manifestations

    Disseminated intravascular coagulation

    Thrombocytopenia

    Haemolysis

    Hepatic manifestations

    Raised serum transaminases

    Severe right upper quadrant or epigastric pain

    Neurological manifestations

    Eclamptic seizure

    Hyperreflexia with sustained clonus

    Severe headache

    Persistent visual disturbances

    Stroke

    Pulmonary oedema

    Fetal growth restriction

    Placental abruption

  • 7/28/2019 Buletin Farmasi 06/2013

    4/12

    seizures in woman with pre-eclampsia.

    Occurs: 1/3 during pregnancy. 1/3 during labour.1/3 postpartum

    Risk factors:

    - 1st pregnancy

    - History of PE

    - Gestational Diabetes Mellitus

    - Chronic HPT

    - Underlying renal disease

    - Obese

    - Rhesus incompatibility

    Characterized by :

    New onset proteinuria (>300mg/24h) in pregnant woman but no proteinuria before 20 weeks

    gestation

    sudden increase proteinuria or BP

    Platelet count

  • 7/28/2019 Buletin Farmasi 06/2013

    5/12

    Medications Starting Dose MaximumDaily Dose

    Diuretics

    Diuretic drugs increase urine output by the

    kidney (i.e., promote diuresis). This is ac-

    complished by altering how the kidney han-

    dles sodium. If the kidney excretes more

    sodium, water excretion will also increase.

    Most diuretics produce diuresis by inhibiting

    the reabsorption of sodium at different seg-

    ments of the renal tubular system.

    Chlorothiazide 250 mg od 500 mg od

    Hydrochlorothiazide 25 mg od 200 mg odChlorthalidone 50 mg od 200 mg od

    Amiloride/

    hydrochlorothiazide 5

    mg/50 mg

    1 tablet od 4 tablet od

    Indapamide SR 1.5 mg od 1.5 mg od

    Indapamide 2.5 mg od 2.5 mg od

    Triamterene/

    hydrochlorothiazide

    50 mg/25 mg

    1 tablet bd 2 tablets bd

    Beta-blockers

    Beta-blockers decrease arterial blood pres-

    sure by reducing cardiac output. Many

    forms of hypertension are associated with

    an increase in blood volume and cardiac

    output. Therefore, reducing cardiac output

    by beta-blockade can be an effective treat-

    ment for hypertension, especially when

    used in conjunction with a diuretic.

    Acebutolol 200 mg bd 400 mg bd

    Atenolol 50 mg od 100 mg od

    Betaxolol 10 mg od 40 mg od

    Bisoprolol 5 mg od 10 mg od

    Metoprolol 50 mg bd 200 mg bd

    Propranolol 40 mg bd 320 mg bd

    ACE inhibitors

    ACE inhibitors are effective in the treatment

    of primary hypertension and hypertension

    caused by renal artery stenosis, which

    causes renin-dependent hypertension ow-

    ing to the increased release of renin by the

    kidneys. Reducing angiotensin II formation

    leads to arterial and venous dilation, which

    reduces arterial and venous pressures. By

    reducing the effects of angiotensin II on thekidney, ACE inhibitors cause natriuresis and

    diuresis, which decreases blood volume and

    cardiac output, thereby lowering arterial

    pressure.

    Captopril 25 mg bd 50 mg tds

    Enalapril 2.5 mg od 20 mg bd

    Fosinopri 10 mg od 40 mg od

    Lisinopril 5 mg od 80 mg od

    Perindopril 2 mg od 8 mg od

    Quinapril 2.5 mg od 40 mg bd

    Ramipril 2.5 mg od 10 mg odImidapril 2.5 mg od 10 mg od

    Angiotensin receptor blockers (ARBs)

    ARBs are receptor antagonists that block

    type 1 angiotensin II (AT1) receptors on

    bloods vessels and other tissues such as the

    heart. These receptors are coupled to theGq-protein and IP3 signal transduction path-

    way that stimulates vascular smooth muscle

    contraction.

    Candesartan 8 mg od 16 mg od

    Irbesartan 150 mg od 300 mg od

    Losartan 50 mg od 300 mg od

    Telmisartan 20 mg od 80 mg od

    Valsartan 80 mg od 160 mg od

    Olmesartan 20 mg od 40 mg od

  • 7/28/2019 Buletin Farmasi 06/2013

    6/12

    -blockers

    Newer alpha-blockers used in treating

    hypertension are relatively selective 1-

    adrenoceptor antagonists. They have

    favourable effects on lipid metabolism.

    Postural hypotension is a known side

    effect, especially at initiation of therapy

    Doxazosin 1 mg od 16 mg od

    Prazosin 0.5 mg bd 10 mg bd

    Terazosin 1 mg od 5 mg od

    Combined -blockers

    Combined -blockers offer enhanced

    neurohormonal blockade.

    Labetalol* 100 mg bd 800 mg tds

    Carvedilol 12.5 mg od 50 mg od

    Medications Starting

    Dose

    Maximum

    Daily Dose

    Amlodipine 5 mg od 10 mg odCalcium channel blockers (CCBs)

    CCBs decrease systemic vascular resis-

    tance by causing vascular smooth mus-

    cle relaxation, which lowers arterial

    blood pressure. There are 2 major

    classes of CCBs. They differ in their rela-tive selectivity toward cardiac versus

    vascular L-type calcium channels

    Dihydropyridines

    Because of their high vascular selectiv-

    ity, these drugs are primarily used to

    reduce systemic vascular resistance

    and arterial pressure, and therefore

    are primarily used to treat hyperten-

    sion. (ie Amlodipine, Felodipine, Is-

    radipine, Lacidipine, Nicardipine,Nifedipine)

    Non-dihydropyridines

    Verapamil (phenylalkylamine class),

    is relatively selective for the myo-

    cardium, and is less effective as a

    systemic vasodilator drug. This

    drug has a very important role in

    treating angina (by reducing myo-

    cardial oxygen demand and re-

    versing coronary vasospasm) andarrhythmias.

    Diltiazem (benzothiazepine class) is

    intermediate between verapamil

    and dihydropyridines in its selec-

    tivity for vascular calcium chan-

    nels. By having both cardiac de-

    pressant and vasodilator actions,

    diltiazem is able to reduce arterial

    pressure without producing the

    same degree of reflex cardiac

    stimulation caused by dihydro-

    pyridines.

    Diltiazem 30 mg tds 60 mg tds

    Diltiazem SR 90 mg bd 90 mg bd

    Diltiazem R 100-200 mg

    od

    100-200 mg

    od

    Felodipine 2.5 mg od 10 mg od

    Isradipine 1.5 mg bd 2.5 mg bd

    Lacidipine 2 mg od 6 mg od

    Lercanidipine 10 mg od 20 mg od

    Nicardipine 10 mg tds 20 mg tds

    Nifedipine 10 mg tds 30 mg tds

    Nifedipine SR 30 mg od 120 mg od

    Verapamil 80 mg bd 240 mg tds

    Verapamil CR 200 mg od 200 mg bd

    * In the elderly, start with 50 mg bd

  • 7/28/2019 Buletin Farmasi 06/2013

    7/12

    EFFECTIVE ANTIHYPERTENSIVE COMBINATION

    Effective combina-

    tion

    Comments

    Beta-blockers + diu-

    retics

    Benefits proven in the elderly, cost-effective. However, may increase

    the risk of new onset diabetes.

    Beta-blockers +

    CCBs

    Relatively cheap, appropriate for concurrent CHD

    CCBs + ACEIs/ARBs Appropriate for concurrent dyslipidaemias and diabetes mellitus

    ACEIs + diuretics Appropriate for concurrent heart failure, diabetes mellitus and stroke

    ARBs + diuretics Appropriate for concurrent heart failure and diabetes mellitus

  • 7/28/2019 Buletin Farmasi 06/2013

    8/12

    NON-PHARMACOLOGICAL :

    BMI or weight

    Salt intake

    Alcohol

    Exercise

    Diet

    Smoking

    As far as possible aim for an ideal Body Mass Index [Weight(kg)/Height2 (m)] forAsians, the normal range has been proposed to be 18.5 to23.5 kg/m2. However a weight loss as little as 4.5 kgsignificantly reduces BP.

    An intake of

  • 7/28/2019 Buletin Farmasi 06/2013

    9/12

    1. Hypertension dikenali sebagai pembunuh senyap kerana

    Ia datang tanpa simptom yang nyata

    Ia adalah perkataan Greek yang bermaksud pembunuh senyap

    Orang dengan hipertension adalah pembunuh

    2. Ubatan hipertension boleh dihentikan apabila tekanan darah kembali normal.

    Betul

    Salah

    3. Tekanan darah kurang dari 120/80 dikira tekanan darah normal untuk orang dewasa.

    Betul

    Salah

    4. Diagnosis tekanan darah tinggi selalunya dibuat selepas beberapa kali peningkatan tekanan

    darah direkod.

    Betul

    Salah

  • 7/28/2019 Buletin Farmasi 06/2013

    10/12

    UBAT BARU LIST A/KK DI KLINIK KESIHATAN UNTUK DI-

    AGNOSIS HIPERTENSI

    Telmisartan/Amlodipine terdapat dalam 2 kekuatan amlodipine:

    ~ Twynsta 80mg/10mg

    ~ Twynsta 80mg/5mg

    PERGERAKAN ANGGOTA FARMASI

    DI PKD PASIR MAS

    Jawatan/Gred Nama Dari Ke

    Penolong Pegawai Farmasi U29 Azira binti Ahmed

    Klinik Kesihatan

    Dabong

    (PKD Kuala Krai)

    Klinik Kesihatan

    Kubang Kual

    (PKD Pasir Mas)

    Penolong Pegawai Farmasi U32

    (KUP)

    Nik Amnah binti Nik

    Idris

    Klinik Kesihatan

    Penambang

    (PKD Kota Bharu)

    Klinik Kesihatan

    Meranti

    (PKD Pasir Mas)

  • 7/28/2019 Buletin Farmasi 06/2013

    11/12

    S ejenak S eketika D i L uar

    POLITIK

    Remaja hipertensi pintar?KESIH

    ATAN

    TEKANAN darah tinggi atau hipertensi bukan sahaja

    dialami oleh golongan dewasa bahkan remaja.Namun,

    remaja yang menghidap penyakit ini didakwa lebih bijak

    serta pintar di sekolah berbanding rakan sebaya yang

    normal.

    Ini berdasarkan penyelidikan sekumpulan pakar pe-

    rubatan di Universiti Gottingen, Jerman terhadap 7,688

    remaja lelaki dan wanita yang berusia antara 11 hingga

    17 tahun. Sebanyak 11 peratus responden menderita

    tekanan darah tinggi.

    EKON

    OMI

    Harga emas jatuh

    DUNIA

    Pihak berkuasa di beberapa negara Asia mengetatkan saringan terhadap pelan-

    cong dari China dalam usaha mengekang penyebaran virus selesema burung

    H7N9 di negara masing-masing. Sehingga Mei, H7N9 telah menjangkiti 109

    orang di China sejak virus itu mula dikesan pada Mac lalu dengan 23 orang

    maut. dan penyakit maut itu telah menjangkiti seorang warga Taiwan.

    Susulan perkembangan tersebut, pihak berkuasa Taiwan memberitahu, mereka

    akan melakukan ujian kesihatan ke atas pelancong di pintu masuk lapanganterbang yang menunjukkan simptom seperti panas badan atau demam.

    Pihak berkuasa Vietnam mula menyaring suhu badan penumpang di lapangan terbang negara itu manakala kerajaan Jepun

    akan membenarkan pihak berkuasa lapangan terbang dan pelabuhan memeriksa suhu badan pelawat dari China bermula

    bulan depan.

    Di Thailand, Menteri Kesihatan Pradit Sintawanarong berkata, negara itu perlu meningkatkan langkah berjaga-jaga dengan

    pelan menangani wabak itu akan diserahkan kepada Perdana Menteri Yingluck Shinawatra tidak lama lagi. "Berdasarkan

    pemerhatian kami, terdapat risiko virus H7N9 merebak ke Thailand," kata Sintawanarong.

    Dalam pada itu, di Singapura, institusi-institusi kesihatan di pulau tersebut kini diletakkan dalam keadaan siapsiaga ber-

    hubung penularan wabak H7N9.

    Langkah tersebut dilaksanakan sehari selepas seorang pakar Pertubuhan Kesihatan Sedunia menyatakan, virus H7N9 meru-

    pakan virus selesema burung yang paling berisiko membawa maut kepada manusia.

    Setakat ini, jangkitan virus berbahaya itu dilaporkan berpunca daripada unggas yang sakit manakala saintis-saintis semakin

    Asia berjaga-jaga penularan selesema H7N9

  • 7/28/2019 Buletin Farmasi 06/2013

    12/12

    The existing body of evidence ... favors

    t h e n o t i o n t h a t p o t a s s i u m

    supplementation should be considered as

    part of recommendations for prevention

    and treatment of hypertension.

    PAUL WHELTON

    Treatment doesn't bring back the risk to that of

    someone without hypertension, ... High blood

    pressure raises the risk threefold and treatment

    reduces it by 25 percent.

    Walter Willett